Biomedcode's mouse model offers the in vivo validation of the efficacy of an improved tacrolimus formulation

Medium_imq-tacrolimus

Biomedcode coauthors a publication in the Journal of Controlled Release on the in vivo non-clinical proof of  the efficacy of a novel composite hydrogel tacrolimus formulation for the treatment of psoriasis.

Read more >

 

Return to News